The cynic in me wouldn’t be surprised if all or part of this investment didn’t eventuate in the interests of propping up their FY21 EBITDA result.
“Appen intends to increase investment in Quadrant’s product and market expansion for the remainder of 2021 and in 2022 to further accelerate growth and expects this will reduce Appen’s FY21 underlying EBITDA by approximately US$2 million.”
MACQUARIE downgrades APX to Underperform from Neutral, page-174
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add APX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
51.0¢ |
Change
0.045(9.68%) |
Mkt cap ! $112.6M | |||
| Open | High | Low | Value | Volume |
| 46.5¢ | 52.0¢ | 46.5¢ | $1.624M | 3.284M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 164553 | 50.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 51.0¢ | 15942 | 6 |
View Market Depth
| Last trade - 15.49pm 12/07/2024 (20 minute delay) ? |
| APX (ASX) Chart |